Future studies should incorporate mechanism-relevant biological markers, including serum BDNF to index neurotrophic signaling, inflammatory markers such as CRP and IL-6, measures of HPA-axis activity such as the cortisol awakening response, and neuroimaging markers (e.g., fMRI-based assessments of hippocampal connectivity), to more precisely characterize treatment response and patient stratification
Energy levels gradually increase Focus and mental clarity begin to improve Mood feels more stable and upbeat With regular doses, B12 levels normalize and cumulative benefits appear
During this early phase, the body is building up glutathione levels in tissues, and the antioxidant effects begin addressing oxidative stress and supporting cellular repair processes
While the overall safety profile is favorable, no injectable treatment is entirely without risk, and patients deserve full disclosure before consenting to the procedure
doi: 10.1021/acs.jafc.9b02102 71 YiX.XuW.ZhouH.ZhangY.LuoY.ZhangW.et al